Precision BioSciences 在欧洲肝病研究学会2026年大会上公布 Eliminate-B 研究的最新及突破性 Pbgene-Hbv 临床数据

美股速递
May 27

Precision BioSciences 公司宣布,其在欧洲肝病研究学会 2026 年大会上,公布了来自 Eliminate-B 研究的最新及突破性 Pbgene-Hbv 临床数据。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10